About

Ibogatrack is an independent information resource on ibogaine for people researching ibogaine. Our work focuses on evidence, safety, legality and practical questions about ibogaine in the context of Texas; this page explains why we exist, how we organize information, and how we vet sources.

Why Ibogatrack exists

Ibogatrack was created to fill a gap: accessible, evidence-focused information tailored to people researching ibogaine in Texas. We aim to make policy documents, trial records, and safety analysis easier to find and understand without acting as a clinic or offering medical guidance. For a concise example of state-level legislative activity we track, readers can follow reporting on the Texas effort via the texasibogainebill.com project site as one context we monitor alongside registries and official notices.

Editorial workspace photograph representing key questions about what ibogaine clinical trials are actually testing, cropped to a square composition

Our editorial approach

We prioritize primary sources and transparent summaries. Where possible we consult trial registries, peer-reviewed literature and official guidance from recognized institutions. That editorial triangulation mirrors standards used by public-health resources; for instance, clinical trial registration practices are outlined on the U.S. National Library of Medicine's registry pages at ClinicalTrials.gov, which informs how we read trial records.

We do not perform original clinical research or offer treatment recommendations. Instead, we synthesize public records and open-access literature into plain-language briefings and timelines so researchers and the public can see the source documents and our summary together.

How we source and vet material

Our sourcing process favors verifiable registries, government statements, and peer-reviewed journals. For legal context and statutes, we consult state and federal government pages; for example, Texas legislative text and session information is typically available from the official state legislature site such as capitol.texas.gov, which we cite when summarizing statutory developments.

What we cover

Ibogatrack curates and summarizes material relevant to people researching ibogaine: trial registrations, safety policy briefs, state-funded timelines, and plain-language explanations of how evidence is gathered. Our pages are organized into navigable hubs — such as a registry index and a safety-policy brief — so readers can move from a high-level overview to the source documents behind each claim.

Who this is for

Our audience includes researchers, clinicians seeking contextual references, journalists checking sources, and members of the public trying to understand developments in Texas. If you arrived here from our homepage overview, you can return to the main site narrative at the front page by following this link to our site overview and entry page.

Editorial principles

  • Independence — we maintain separation from providers and funders when publishing summaries.
  • Plain language — technical material is translated without altering the underlying sources.
  • Evidence-first — claims are tied to registries, official documents, or peer-reviewed literature.
  • No fabricated credentials — we avoid asserting authority we cannot document.

Independent by design

Ibogatrack is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice. We encourage readers to consult official registries and licensed professionals for clinical or legal decisions; for general context about how scholarly publishing and peer review function, the entry at Wikipedia's peer review article provides a brief overview of common practices in research evaluation.

"Transparency and primary-source linkage are central to our work — we show what we read so readers can judge for themselves."

For readers interested in services related to data or documentation support, our editorial descriptions link naturally to the site's services hub where we list the types of summaries and indexes we maintain; see the brief services overview at the services page to understand how we package registry summaries and timelines.

FAQ

Is Ibogatrack a medical provider?

No. Ibogatrack provides informational summaries and links to source documents. We are not a clinic or medical provider and do not provide medical advice.

Where do you get your information?

We rely primarily on trial registries, government publications, and peer-reviewed literature. We also cite authoritative institutional sources when summarizing standards; for guidance on clinical trial reporting standards, the World Health Organization maintains resources at who.int.

How can I report an error or suggest a source?

We welcome suggestions. Use the Contact link in the site navigation to reach our editorial team; that page provides a direct route for suggesting corrections or submitting public records you believe we should review. The Contact link is available in the header and footer navigation.

Do you track legislation in Texas?

Yes — our focus includes Texas context and timelines. We monitor official sources and public trackers for state activity; one public project that collects information around state-level proposals is maintained at texasibogainebill.com, which we reference when summarizing local developments.